The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome

Hugo Arias-Pulido,Ashley Cimino-Mathews,Nabila Chaher,Clifford Qualls,Nancy E. Joste,C. Colpaert,Jonathan D. Marotti,M. Foisey,Eric R. Prossnitz,Leisha A. Emens,Steven Fiering

The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome

2018

Hugo Arias-Pulido
Ashley Cimino-Mathews
Nabila Chaher
Clifford Qualls
Nancy E. Joste
C. Colpaert
Jonathan D. Marotti
M. Foisey
Eric R. Prossnitz
Leisha A. Emens
Steven Fiering

Purpose The purpose of the study was to evaluate protein expression of PD-L1 and CD20 as prognostic biomarkers of patient outcome in inflammatory breast cancer (IBC) samples.

Keywords:

Cancer research
PD-L1
CD20
Protein expression
Biomarker (medicine)
Medicine
Tumor-infiltrating lymphocytes
Inflammatory breast cancer
Immunohistochemistry
Survival analysis
Hazard ratio
Stromal cell

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations